Profile
| Metric | Value |
|---|---|
| Full Name | Bausch + Lomb Corporation |
| Ticker | NYSE: BLCO |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | bausch.com |
| Employees | 13,500 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.31 | |
| Price, 1D Change | +0.07% | |
| Market Cap | $6B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.27 | |
| Revenue | $5B | |
| Revenue, 1Y Change | +15.56% | |
| EPS | -$0.90 | |
| EPS, 1Y Change | -21.47% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.90 | |
| EPS Estimate | $0.53 | |
| EPS Est. Change | +158.83% | |
| Revenue | $4.79B | |
| Revenue Estimate | $5.08B | |
| Revenue Est. Change | +5.99% | |
| Current Price | $17.31 | |
| Price Target | - | $17.00 |
| Price Tgt. Change | - | -1.80% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.91 | -$0.74 | -181.52% | |
| $0.59 | -$0.90 | -253.93% | |
| $0.53 | N/A | +158.83% | |
| $0.78 | N/A | +186.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.50B | $4.15B | -24.67% | |
| $4.77B | $4.79B | +0.52% | |
| $5.08B | N/A | +5.99% | |
| $5.38B | N/A | +12.32% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -4.25% | |
| Price, 3Y | +7.12% | |
| Market Cap, 1Y | -3.77% | |
| Market Cap, 3Y | +8.41% | |
| Revenue, 1Y | +15.56% | |
| Revenue, 3Y | +27.25% | |
| EPS, 1Y | -21.47% | |
| EPS, 3Y | -100.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.31 | |
| SMA 200 | $14.22 | |
| SMA 200 vs Price | -17.87% | |
| SMA 50 | $16.28 | |
| SMA 50 vs Price | -5.97% | |
| Beta | 1.27 | |
| ATR | $0.41 | |
| 14-Day RSI | 59.95 | |
| 10-Day Volatility | 22.37% | |
| 1-Year Volatility | 44.11% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.79B | |
| EPS | -$0.90 | |
| Gross Profit | $2.92B | |
| Gross Margin | 60.93% | |
| Operating Profit | $188.00M | |
| Operating Margin | 3.92% | |
| Net Income | -$305.00M | |
| Net Margin | -6.62% | |
| EBITDA | $601.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.76 | |
| Current Ratio | 1.60 | |
| Quick Ratio | 1.01 | |
| Interest Coverage | 0.41 | |
| F-Score | 3 | |
| Altman Z-Score | 0.96 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 1.23 | |
| PB Ratio | 0.95 | |
| EV/EBITDA | 18.86 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $6.47B | |
| Cash & Equivalents | $316.00M | |
| Total Assets | $13.47B | |
| Current Assets | $2.79B | |
| Total Liabilities | $6.93B | |
| Current Liabilities | $1.74B | |
| Total Debt | $4.94B | |
| Short Term Debt | $72.00M | |
| Accounts Payable | $389.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $4.60B | |
| Operating Expenses | $2.73B | |
| Cost Of Goods Sold | $1.87B | |
| SG&A | $2.08B | |
| D&A | $436.00M | |
| Interest Expense | $399.00M | |
| Income Tax | $71.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $232.00M | |
| CFI | -$412.00M | |
| CFF | $178.00M | |
| Capex | $291.00M | |
| Free Cash Flow | -$59.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Wells Fargo | → | |
| Raymond James | → | |
| JP Morgan | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with BLCO
Data Sources & References
- BLCO Official Website www.bausch.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1860742/000186074225000023/0001860742-25-000023-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1860742/000186074225000004/0001860742-25-000004-index.htm
- BLCO Profile on Yahoo Finance finance.yahoo.com/quote/BLCO
- BLCO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/blco
FAQ
What is the ticker symbol for Bausch + Lomb Corporation?
The ticker symbol for Bausch + Lomb Corporation is NYSE:BLCO
Does Bausch + Lomb Corporation pay dividends?
No, Bausch + Lomb Corporation does not pay dividends
What sector is Bausch + Lomb Corporation in?
Bausch + Lomb Corporation is in the Healthcare sector
What industry is Bausch + Lomb Corporation in?
Bausch + Lomb Corporation is in the Medical Instruments & Supplies industry
What country is Bausch + Lomb Corporation based in?
Bausch + Lomb Corporation is headquartered in Canada
When did Bausch + Lomb Corporation go public?
Bausch + Lomb Corporation initial public offering (IPO) was on May 6, 2022
Is Bausch + Lomb Corporation in the S&P 500?
No, Bausch + Lomb Corporation is not included in the S&P 500 index
Is Bausch + Lomb Corporation in the NASDAQ 100?
No, Bausch + Lomb Corporation is not included in the NASDAQ 100 index
Is Bausch + Lomb Corporation in the Dow Jones?
No, Bausch + Lomb Corporation is not included in the Dow Jones index
When was Bausch + Lomb Corporation last earnings report?
Bausch + Lomb Corporation's most recent earnings report was on October 29, 2025
When does Bausch + Lomb Corporation report earnings?
The next expected earnings date for Bausch + Lomb Corporation is February 18, 2026